Indicative 1 April 2018 Prices - 2018 April Cycle
Page last updated: 7 March 2018
Please note: The information on this page has been updated following amendments to the National Health (Weighted average disclosed price – April 2018 reduction day) Determination 2018. Amendments were made to reflect changes to the price disclosure requirements under Division 3B of the National Health Act 1953 by the National Health Amendment (Pharmaceutical Benefits—Budget and Other Measures) Act 2018 that received Royal Assent on 20 February 2018.
These prices may change if there are changes in prices or listings before 1 April 2018 (e.g., lower price / pricing quantity changes). The spreadsheets do not include flow-on price disclosure reductions for combination drugs or F2 combination drugs (F2 combination drugs that are taking a direct price disclosure reduction have been included), new brands after January 2018 or brands with other price changes on the reduction day. Those other prices will be available publicly on 1 April 2018. Combination Drugs taking Flow-on Price Reductions for 1 April 2018 will be published on the Pricing Matters web page in early March 2018.
- Indicative 1 April 2018 prices – 2018 April cycle (EFC only) (Excel 15KB)
- Indicative 1 April 2018 prices – 2018 April cycle (EFC only) (PDF 45KB)
- Indicative 1 April 2018 prices – 2018 April cycle (excluding EFC medicines) (Excel 239KB)
- Indicative 1 April 2018 prices - 2018 April cycle (excluding EFC medicines) (PDF 339KB)